Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)

✍ Scribed by Nestor Mercado; Jasper J. Brugts; Joachim H. Ix; Michael G. Shlipak; Simon R. Dixon; Bernard J. Gersh; Pedro A. Lemos; Mimi Guarneri; Paul S. Teirstein; William Wijns; Patrick W. Serruys; Eric Boersma; William W. O'Neill

• Book ID: 113445049
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 98 KB
• Volume: 102
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/j.amjcard.2008.06.035